LIVESTRONG Foundation Gift to Dell Medical School Allows UT Austin to Surpass $3 Billion Campaign Goal
With a $50 million gift from the LIVESTRONG Foundation to the Dell Medical School, The University of Texas at Austin has exceeded its goal of raising $3 billion during the eight-year Campaign for Texas.Read more
The $50 million gift will establish the LIVESTRONG Cancer Institutes at the Dell Medical School. Read more about how the partnership will advance a new model of patient-centered care.Read more
Researchers have determined that postmenopausal overweight or obese breast cancer patients receiving hormone therapy as part of their treatment and who use nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen have significantly lower breast cancer recurrence rates and a sizable delay in time to cancer recurrence.Read more
AUSTIN, Texas Researchers from The University of Texas at Austin and five other institutions have created a molecule that can cause cancer cells to self-destruct by ferrying sodium and chloride ions into the cancer cells.
These synthetic ion transporters, described this week in the journal Nature Chemistry, confirm a two-decades-old hypothesis that could point the way to new anticancer drugs while also benefiting patients with cystic fibrosis.Read more
EVENT: The university's first Computational Medicine Day.
WHEN: May 13, 2014.Read more